Universität zu Köln

2022

Franklin, Cindy ORCID: 0000-0001-9142-5423, Mohr, Peter, Bluhm, Leonie, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund ORCID: 0000-0003-4340-9706, Garzarolli, Marlene, Weichenthal, Michael ORCID: 0000-0002-9060-4961, Pfoehler, Claudia, Herbst, Rudolf ORCID: 0000-0002-4238-9486, Terheyden, Patrick, Utikal, Jochen, Ulrich, Jens, Debus, Dirk, Haferkamp, Sebastian, Kaatz, Martin, Forschner, Andrea, Leiter, Ulrike, Nashan, Dorothee, Kreuter, Alexander, Sachse, Michael, Welzel, Julia, Heinzerling, Lucie, Meiss, Frank, Weishaupt, Carsten, Gambichler, Thilo, Weyandt, Gerhard, Dippel, Edgar, Schatton, Kerstin, Celik, Eren, Trommer, Maike, Helfrich, Iris, Roesch, Alexander, Zimmer, Lisa ORCID: 0000-0002-3680-3521, Livingstone, Elisabeth, Schadendorf, Dirk, Horn, Susanne and Ugurel, Selma (2022). Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. J. Immunother. Cancer, 10 (6). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Koch, Elias A. T., Petzold, Anne, Wessely, Anja ORCID: 0000-0003-1940-5115, Dippel, Edgar, Gesierich, Anja, Gutzmer, Ralf, Hassel, Jessica C., Haferkamp, Sebastian, Kaehler, Katharina C., Knorr, Harald, Kreuzberg, Nicole, Leiter, Ulrike ORCID: 0000-0002-8019-1577, Loquai, Carmen, Meier, Friedegund ORCID: 0000-0003-4340-9706, Meissner, Markus ORCID: 0000-0002-5630-587X, Mohr, Peter ORCID: 0000-0002-7328-7407, Pfoehler, Claudia, Rahimi, Farnaz, Schadendorf, Dirk ORCID: 0000-0003-3524-7858, Schell, Beatrice, Schlaak, Max ORCID: 0000-0002-1663-8098, Terheyden, Patrick, Thoms, Kai-Martin, Schuler-Thurner, Beatrice, Ugurel, Selma ORCID: 0000-0002-9384-6704, Ulrich, Jens, Utikal, Jochen ORCID: 0000-0001-5316-0241, Weichenthal, Michael ORCID: 0000-0002-9060-4961, Ziller, Fabian, Berking, Carola ORCID: 0000-0003-0229-8931 and Heppt, Markus V. (2022). Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers, 14 (3). BASEL: MDPI. ISSN 2072-6694

2021

Knispel, Sarah, Gassenmaier, Maximilian, Menzies, Alexander M., Loquai, Carmen, Johnson, Douglas B., Franklin, Cindy ORCID: 0000-0001-9142-5423, Gutzmer, Ralf, Hassel, Jessica C., Weishaupt, Carsten, Eigentler, Thomas, Schilling, Bastian, Schummer, Patrick, Sirokay, Judith ORCID: 0000-0003-3945-845X, Kiecker, Felix, Owen, Carina N., Fleischer, Maria, I, Cann, Christopher, Kaehler, Katharina C., Mohr, Peter, Bluhm, Leonie, Niebel, Dennis ORCID: 0000-0003-2069-0486, Thoms, Kai-Martin, Goldinger, Simone M., Reinhardt, Lydia, Meier, Friedegund, Berking, Carola, Reinhard, Raphael, Susok, Laura, Ascierto, Paolo A., Drexler, Konstantin, Pfoehler, Claudia, Tietze, Julia, Heinzerling, Lucie, Livingstone, Elisabeth, Ugurel, Selma, Long, Georgina, V, Stang, Andreas, Schadendorf, Dirk and Zimmer, Lisa ORCID: 0000-0002-3680-3521 (2021). Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition. Eur. J. Cancer, 148. S. 61 - 76. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Koch, Elias A. T., Petzold, Anne, Wessely, Anja ORCID: 0000-0003-1940-5115, Dippel, Edgar, Gesierich, Anja, Gutzmer, Ralf, Hassel, Jessica C., Haferkamp, Sebastian ORCID: 0000-0002-3894-8345, Hohberger, Bettina, Kaehler, Katharina C., Knorr, Harald, Kreuzberg, Nicole, Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund, Meissner, Markus, Mohr, Peter, Pfoehler, Claudia, Rahimi, Farnaz, Schadendorf, Dirk, Schell, Beatrice, Schlaak, Max, Terheyden, Patrick, Thoms, Kai-Martin, Schuler-Thurner, Beatrice, Ugurel, Selma, Ulrich, Jens, Utikal, Jochen, Weichenthal, Michael, Ziller, Fabian, Berking, Carola and Heppt, Markus V. (2021). Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis. Cancers, 13 (13). BASEL: MDPI. ISSN 2072-6694

2020

Knispel, Sarah, Stang, Andreas, Zimmer, Lisa, Lax, Hildegard, Gutzmer, Ralf, Heinzerling, Lucie, Weishaupt, Carsten, Pfoehler, Claudia, Gesierich, Anja, Herbst, Rudolf, Kaehler, Katharina C., Weide, Benjamin, Berking, Carola, Loquai, Carmen, Utikal, Jochen, Terheyden, Patrick, Kaatz, Martin, Schlaak, Max, Kreuter, Alexander, Ulrich, Jens, Mohr, Peter, Dippel, Edgar, Livingstone, Elisabeth, Becker, Juergen C., Weichenthal, Michael, Chorti, Eleftheria, Gronewold, Janine, Schadendorf, Dirk and Ugurel, Selma (2020). Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG. J. Immunother. Cancer, 8 (1). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Koutzamanidis, Rafaela, Mentzer, Dirk, Knauss, Samuel, Broeckelmann, Paul J., Hassel, Jessica Cecile, Ugurel-Becker, Selma, Pavel, Marianne, Nickel, Florian, Landendinger, Melanie, Fuchs, Florian, Meidenbauer, Norbert, Jefremow, Andre, Manger, Bernhard, Gutzmer, Ralf, Loguai, Carmen, Kaehler, Katharina, Zimmer, Lisa, Berking, Carola, Keller-Stanislawski, Brigitte, Heinzerling, Lucie, Erdrnann, Michael, Kirchberger, Michael C. and Toussaint, Frederic (2020). Serio - Side Effect Registry in Immuno-Oncology. Oncol. Res. Treat., 43. S. 231 - 232. BASEL: KARGER. ISSN 2296-5262

Leiter, Ulrike, Loquai, Carmen, Reinhardt, Lydia, Rafei-Shamsabadi, David, Gutzmer, Ralf, Kaehler, Katharina, Heinzerling, Lucie, Hassel, Jessica C., Glutsch, Valerie, Sirokay, Judith, Schlecht, Nora, Rubben, Albert, Gambichler, Thilo, Schatton, Kerstin, Pfoehler, Claudia, Franklin, Cindy, Terheyden, Patrick, Haferkamp, Sebastian, Mohr, Peter, Bischof, Lena, Livingstone, Elisabeth, Zimmer, Lisa, Weichenthal, Michael, Schadendorf, Dirk, Meiwes, Andreas, Keim, Ulrike, Garbe, Claus, Becker, Jurgen Christian and Ugurel, Selma (2020). Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. J. Immunother. Cancer, 8 (2). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

2019

Menzer, Christian, Menzies, Alexander M., Carlino, Matteo S., Reijers, Irene, Groen, Emma J., Eigentler, Thomas, de Groot, Jan Willem B., van der Veldt, Astrid A. M., Johnson, Douglas B., Meiss, Frank, Schlaak, Max, Schilling, Bastian, Westgeest, Hans M., Gutzmer, Ralf, Pfoehler, Claudia, Meier, Friedegund, Zimmer, Lisa, Suijkerbuijk, Karijn P. M., Haalck, Thomas, Thoms, Kai-Martin, Herbschleb, Karin, Leichsenring, Jonas, Menzer, Alexander, Kopp-Schneider, Annette, Long, Georgina V., Kefford, Richard ORCID: 0000-0001-9251-9229, Enk, Alexander, Blank, Christian U. and Hassel, Jessica C. (2019). Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations. J. Clin. Oncol., 37 (33). S. 3142 - 3163. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2018

Hassel, Jessica Cecile, Menzer, Christian, Menzies, Alexander M., Carlino, Matteo S., Long, Georgina V., Kefford, Richard, Eigentler, Thomas K., Johnson, Douglas Buckner, Schlaak, Max, Meiss, Frank, Schilling, Bastian ORCID: 0000-0001-8859-4103, Gutzmer, Ralf, Pfoehler, Claudia, Meier, Friedegund Elke, Zimmer, Lisa, Haalck, Thomas, Thoms, Kai, Kopp-Schneider, Annette and Enk, Alexander (2018). BRAF/MEK inhibition in melanoma patients with rare BRAF mutations. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kaehler, Katharina C., Eigentler, Thomas K., Gesierich, Anja, Heinzerling, Lucie, Loquai, Carmen, Meier, Friedegund, Meiss, Frank, Pfoehler, Claudia, Schlaak, Max, Terheyden, Patrick, Thoms, Kai M., Ziemer, Mirjana, Zimmer, Lisa and Gutzmer, Ralf (2018). Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders. Cancer Immunol. Immunother., 67 (5). S. 825 - 835. NEW YORK: SPRINGER. ISSN 1432-0851

2017

Heppt, Markus V., Roesch, Alexander, Weide, Benjamin, Gutzmer, Ralf, Meier, Friedegund, Loquai, Carmen, Kaehler, Katharina C., Gesierich, Anja, Meissner, Markus, von Bubnoff, Dagmar, Goeppner, Daniela, Schlaak, Max, Pfoehler, Claudia, Utikal, Jochen ORCID: 0000-0001-5316-0241, Heinzerling, Lucie, Cosgarea, Ioana, Engel, Jutta, Eckel, Renate, Martens, Alexander, Mirlach, Laura, Satzger, Imke, Schubert-Fritschle, Gabriele, Tietze, Julia K. and Berking, Carola (2017). Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur. J. Cancer, 81. S. 36 - 45. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

2016

Hassel, Jessica Cecile, Forschner, Andrea, Blum, Leonie, Heinzerling, Lucie, Zimmer, Lisa, Utikal, Jochen, Kahler, Katharina C., Schlaak, Max, Loquai, Carmen, Gutzmer, Ralf, Kiecker, Felix, Berking, Carola, Bender, Armin, Schneider, Lars, Enk, Alexander, Garbe, Claus, Weichenthal, Michael, Schadendorf, Dirk, Hauschild, Axel and Mohr, Peter (2016). Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP). J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Weide, Benjamin, Martens, Alexander, Hassel, Jessica C., Berking, Carola, Postow, Michael A., Bisschop, Kees, Simeone, Ester, Mangana, Johanna, Schilling, Bastian ORCID: 0000-0001-8859-4103, Di Giacomo, Anna Maria, Brenner, Nicole, Kaehler, Katharina, Heinzerling, Lucie, Gutzmer, Ralf, Bender, Armin, Gebhardt, Christoffer ORCID: 0000-0001-7090-9584, Romano, Emanuela, Meier, Friedegund, Martus, Peter, Maio, Michele ORCID: 0000-0002-0323-6321, Blank, Christian, Schadendorf, Dirk, Dummer, Reinhard, Ascierto, Paolo A., Hospers, Geke, Garbe, Claus ORCID: 0000-0001-8530-780X and Wolchok, Jedd D. (2016). Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab. Clin. Cancer Res., 22 (22). S. 5487 - 5497. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

2015

Mohr, Peter, Hauschild, Axel, Trefzer, Uwe, Enk, Alexander, Tilgen, Wolfgang, Loquai, Carmen, Gogas, Helen, Haalck, Thomas, Koller, Josef, Dummer, Reinhard, Gutzmer, Ralf, Brockmeyer, Norbert, Hoelzle, Erhard, Sunderkoetter, Cord, Mauch, Cornelia, Stein, Annette, Schneider, Lars A., Podda, Maurizio, Goeppner, Daniela, Schadendorf, Dirk and Weichenthal, Michael (2015). Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial. J. Clin. Oncol., 33 (34). S. 4077 - 4087. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755